1 Min Read
AMSTERDAM, June 28 (Reuters) - Philips, the Dutch medical equipment maker, said on Wednesday it will acquire U.S.-based Spectranetics Corp for 1.9 billion euros ($2.16 billion), including debt, in a deal agreed with the company's boards.
Spectranetics uses techniques including lasers and tiny drug-covered balloons to clean the insides of veins and arteries that have become clogged due to heart disease.
Separately, Philips announced a new 1.5 billion euro share buyback program that will begin in the third quarter and run for two years. ($1 = 0.8803 euros) (Reporting by Toby Sterling; Editing by Muralikumar Anantharaman)